Definium Therapeutics, Inc.

DFTX · Nasdaq · SIC 2833: Medicinal Chemicals & Botanical Products
145
SEC Filings

Business Summary

PART I . Overview We are a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. We are developing a pipeline of innovative product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This specifically includes pharmaceutic...

Next Earnings

Q2 FY2026 — expected 2026-09-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionDFTXdiscussed_in_filing Cybersecurity
topic_mentionDFTXdiscussed_in_filing Cybersecurity
topic_mentionDFTXdiscussed_in_filing Healthcare & Bio
topic_mentionDFTXdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-076742EDGAR100K words
2025-03-062024-12-310000950170-25-034176EDGAR—
2024-02-282023-12-310000950170-24-021656EDGAR—
2023-03-092022-12-310000950170-23-007053EDGAR—
2022-03-282021-12-310000950170-22-004724EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-269596EDGAR22K words
2025-07-312025-06-300000950170-25-100925EDGAR—
2025-05-082025-03-310000950170-25-066387EDGAR—
2024-11-072024-09-300000950170-24-123391EDGAR—
2024-08-132024-06-300000950170-24-095753EDGAR—
2024-05-082024-03-310000950170-24-055681EDGAR—
2023-11-022023-09-300000950170-23-058248EDGAR—
2023-08-032023-06-300000950170-23-038057EDGAR—
2023-05-042023-03-310000950170-23-017907EDGAR—
2022-11-102022-09-300000950170-22-024192EDGAR—
2022-08-112022-06-300000950170-22-016893EDGAR—
2022-05-162022-03-310000950170-22-009955EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001193125-26-076612EDGAR3K words
2026-01-290001193125-26-028186EDGAR—
2026-01-120001193125-26-009854EDGAR—
2025-11-060001193125-25-269548EDGAR—
2025-10-310001104659-25-104696EDGAR—
2025-10-290001104659-25-103726EDGAR—
2025-09-040000950170-25-112973EDGAR—
2025-07-310000950170-25-100902EDGAR—
2025-06-160000950170-25-086830EDGAR—
2025-05-270001104659-25-052719EDGAR—

145 total filings indexed. 118 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

AIBT — AIBOTICS, INC. ADIA — Adia Nutrition, Inc. AAWH — Ascend Wellness Holdings, Inc. CYAN — CYANOTECH CORP TCRG — Cannaisseur Group Inc. CGC — Canopy Growth Corp CHUC — Charlie's Holdings, Inc. CFOO — China Foods Holdings Ltd.

Company Identity

CIK0001813814
TickerDFTX
ExchangeNasdaq
SIC2833: Medicinal Chemicals & Botanical Products
IncorporatedA1

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 89f5bd05da8d2cfa9176490a1db1712fb93505c25df9d049e3ca40e638972b8a
parent: b8dcb93a1c28256b6facb3452a89f97a2bc91f49b78b7ef4495e68d281648049
content hash: 3d721bcabbb5eb81e066813b7a9844bb5ec007349b8ad494073c466bf74f44b7
signed: 2026-04-13T04:44:38.922Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf